| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9260956 | Allergology International | 2005 | 9 Pages |
Abstract
These results indicate that %EOS and %BASO are good candidates to predict the response to suplatast among patients with moderate to severe bronchial asthma on inhaled steroid therapy. These predictors may contribute, in combination with genomic information, to stratified medical treatment tailored to the individual needs of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Takemasa Nakagawa, Yoshihiro Okayama, Toshinori Oka, Terumasa Miyamoto, on behalf of the IPD Research Group for Asthma on behalf of the IPD Research Group for Asthma,